NCT06109311 · Interventional trial
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor
Overall registry status Completed
Phase 3
Conditions Type 2 Diabetes
Delaware Valley sites
- Tristar Clinical Investigations · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory